Advik Laboratories Ltd - 531686 - Statement Of Investor Complaints For The Quarter Ended 30Thseptember, 2026

MPS PHARMAA LIMITED (Formerly Advik Laboratories Limited) Dated: 10/10/2026 The Manager (Listing), BSE Limited, 01st Floor, P. J. Towers, Dalal Street, Mumbai – 400001 Subject: Statement of Investor Complaints for the quarter ended 30thSeptember, 2026 Ref: BSE Scrip Code– 531686; ASE Scrip Code– 01636 (ADVIK LABO) Dear Sir, As per the requirements of Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herein below the Statement of Investor Complaints for the quarter ended 30thSeptember, 2026 for your kind perusal: Number of Investor Number of Investor Number of Investor Number of Investor Complaints pending at Complaints received Complaints disposed of Complaints remaining the beginning of the during the quarter during the quarter unresolved at the end of quarter ending on 30th ending on 30th ending on 30th the quarter, i.e. on 30th September, 2026, i.e. on September, 2026, i.e. September, 2026, i.e. September, 2026 01st July, 2026 from 01st July, 2026 to from 01st July, 2026 to 30th September 2026 30th September, 2026 NIL NIL NIL NIL This is for your information and records please. Thanking You. Yours Faithfully, For MPS Pharmaa Limited (Formerly Advik Laboratories Limited) Pooja Chuni Company Secretary The Manager (Listing) Ahmedabad Stock Exchange Ltd., 01st Floor, Kamdhenu Complex, Opp. Sahajanand College, Panjarapole, Ambawadi, Ahmedabad - 380015 CIN No. : L74899HR1994PLC038300 Corporate Office : 703, Arunachal building 19, Barakhamba Road, Connaught Place, New Delhi 110001 Phones: 011-42424884, 43571040-45, Fax: 011-43571047 Regd. Office & Factory: 138. Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt.Mewat), Haryana Phones: 0124-2362471 Email:info@mpspharmaa.comWebsite: www.mpspharmaa.com